carbenoxolone sodium has been researched along with c.i. 42510 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelley, M; Li, L; Vessey, DA | 1 |
| Cervetto, C; Di Cesare Mannelli, L; Ghelardini, C; Marcoli, M; Maura, G; Micheli, L; Zanardelli, M | 1 |
2 other study(ies) available for carbenoxolone sodium and c.i. 42510
| Article | Year |
|---|---|
Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning.
Topics: Adenosine; Adenosine Triphosphate; Animals; Carbenoxolone; Connexins; Ischemic Preconditioning, Myocardial; Lysophospholipids; Mefloquine; Myocardial Reperfusion Injury; Nerve Tissue Proteins; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Sphingosine | 2010 |
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
Topics: Analgesics; Animals; Antineoplastic Agents; Benzenesulfonates; Carbenoxolone; Cell Death; Cell Line, Tumor; Cerebral Cortex; Colonic Neoplasms; Connexins; Glutamic Acid; Humans; Male; Nerve Tissue Proteins; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Purinergic P2X Receptor Antagonists; Pyridines; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Synaptosomes; Tetrazoles | 2015 |